Phoenix Financial Ltd.’s Teva Pharmaceutical Inds Ltd Position
Does Phoenix Financial Ltd. own Teva Pharmaceutical Inds Ltd (TEVA)? Yes — 42.78M shares worth $1.3B (+12.21% of its 13F portfolio) as of Q1 2026, up from 41.09M shares the prior filed quarter.
Position Value
$1.3B
Q1 2026
Shares
42.78M
% of Portfolio
+12.21%
Quarters Held
27
currently held
Position History TEVA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 42.78M | $1.3B | +12.21% |
| Q4 2025 | 41.09M | $1.3B | +13.90% |
| Q3 2025 | 82.59M | $1.7B | +10.62% |
| Q2 2025 | 37.76M | $633M | +8.35% |
| Q1 2025 | 27.46M | $422M | +6.46% |
| Q4 2024 | 21.21M | $468M | +6.38% |
| Q3 2024 | 22.56M | $407M | +6.01% |
| Q2 2024 | 25.42M | $413M | +6.29% |
| Q1 2024 | 34.58M | $488M | +6.74% |
| Q4 2023 | 34.38M | $404M | +6.69% |
| Q3 2023 | 34.48M | $352M | +6.56% |
| Q2 2023 | 33.70M | $254M | +5.19% |
| Q1 2023 | 22.13M | $196M | +4.38% |
| Q4 2022 | 22.16M | $202M | +3.91% |
| Q3 2022 | 20.83M | $163M | +3.59% |
| Q2 2022 | 18.53M | $139M | +2.85% |
| Q1 2022 | 16.70M | $157M | +2.64% |
| Q4 2021 | 15.19M | $122M | +2.01% |
| Q3 2021 | 14.17M | $138M | +2.39% |
| Q2 2021 | 11.55M | $114M | +2.18% |
| Q1 2021 | 11.58M | $134M | +3.02% |
| Q4 2020 | 8.62M | $83M | +2.23% |
| Q3 2020 | 11.15M | $95M | +3.96% |
| Q2 2020 | 11.68M | $137M | +5.80% |
| Q1 2020 | 11.33M | $99M | +5.03% |
| Q4 2019 | 6.60M | $64M | +2.68% |
| Q3 2019 | 5.23M | $34M | +1.63% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Phoenix Financial Ltd.’s full portfolio or all institutional holders of TEVA.